Cue biopharma to present at two upcoming investor healthcare conferences in november

Boston, nov. 09, 2022 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate tumor-specific t cells directly within the patient's body, announced today that it will present at two investor conferences this november, the stifel healthcare conference 2022, to be held november 15-16 in new york, and the jefferies london healthcare conference, to be held in london, uk, november 15-17.
CUE Ratings Summary
CUE Quant Ranking